September / October 2018 Issue of Becker's Spine Review
The Latest
Jeremy Thomas, DO, pleaded guilty to opioid prescription drug conspiracies in five federal cases, according to a Claremore Progress report.
An orthopedic surgeon will lead Cleveland Clinic's Florida region under a restructuring plan that would begin early next year.
SpinalCyte received FDA Investigational New Drug clearance for CybroCell, its fibroblast-based therapy to treat degenerative disc disease.
FloSpine is a spinal implant company.
CMS released the Procedure Price Lookup tool, which provides the average payment to ASCs and HOPDs for select procedures. The data also shows the average patient copays without Medicare supplemental insurance.
Total knee replacement surgeries are projected to increase 673 percent to 3.5 million procedures annually by 2030, according to A Nation in Motion, an educational initiative by the American Academy of Orthopaedic Surgeons.
Siva Sriharan, MD, is a board-certified neurosurgeon at Neurosurgical Specialists of North Florida in Gainesville.
Researchers implanted tissue-engineered spinal discs in a goat model which provided long-term function, according to a study in Science Translational Medicine.
The FDA will overhaul its 510(k) clearance pathway for medical devices.